The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer
BEVATOMOX II期试验:雷替曲塞/奥沙利铂/贝伐单抗对比mFOLFOX6/贝伐单抗治疗二线转移性结直肠癌
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyag006
Samalin, Emmanuelle; Senellart, Hélène; Thezenas, Simon; Jacquot, Stéphane; Ellis, Stephen; Akouz, Faiza Khemissa; Fiess, Catherine; Ramdani, Mohamed; Portales, Fabienne; Assenat, Eric; Ychou, Marc; Mineur, Laurent; Mazard, Thibault